Biotechnology
Novartis not joining the ‘frenzy’ of weight loss drugs, CEO says
The CEO of Novartis said Wednesday that the Swiss pharmaceutical giant does not plan to enter into the “frenzy” of ...
Pfizer’s cancer cachexia drug shows positive midstage trial results
Pfizer‘s experimental drug for a common, life-threatening condition that causes cancer patients to lose their appetite and weight showed positive ...
FDA authorizes Novavax Covid vaccine targeting JN.1
A vial labelled “Novavax V COVID-19 Vaccine” is seen in this illustration taken January 16, 2022. Dado Ruvic | Reuters ...
Eli Lilly releases new, cheaper form of weight loss drug
Eli Lilly on Tuesday released a new form of its weight loss drug Zepbound for roughly half its usual monthly ...
Eli Lilly weight loss drug cuts risk of developing diabetes in trial
An Eli Lilly & Co. Zepbound injection pen arranged in the Brooklyn borough of New York, US, on Thursday, March ...
Ro launches GLP-1 insurance coverage checker
Zoom In IconArrows pointing outwards The direct-to-consumer health-care startup Ro launched a new free tool Tuesday to help patients determine ...
Eli Lilly (LLY) earnings Q2 2024
Eli Lilly on Thursday reported second-quarter earnings and revenue that blew past expectations and hiked its full-year revenue outlook by ...
CVS Health (CVS) earnings Q2 2024
The CVS pharmacy logo is displayed on a sign above a CVS Health Corp. store in Las Vegas, Nevada on ...
Eli Lilly Zepbound, Mounjaro available after shortages, FDA says
An injection pen of Zepbound, Eli Lilly’s weight loss drug, is displayed in New York City on Dec. 11, 2023. ...